Eplontersen, sold under the brand name Wainua, is a medication used for the treatment of transthyretin-mediated amyloidosis. It is a transthyretin-directed antisense oligonucleotide. From Wikipedia
The pharmaceutical giant reports a robust fiscal year 2023, with significant revenue growth and optimistic forecasts for the coming year.
